For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Getafe 28905

0 studies enrolling now · 9 studies all time

What they study most

Alzheimer's Disease, Chronic Low Back Pain, Osteoarthritis Knee Pain, Rheumatoid Arthritis, Sepsis

Studies at this site

• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease — Stopped early
• A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
• Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease — Stopped early
• Effect of LY2062430 on the Progression of Alzheimer's Disease — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• A Study of Duloxetine in Patients With Osteoarthritis Knee Pain — Completed
• A Study for Patient With Chronic Low Back Pain — Completed